This live session provides a focused overview of hallucinogen use and related disorders in addiction medicine, emphasizing the clinical effects, risks, and emerging therapeutic applications of psychedelics and other hallucinogenic substances.
What This Includes
• Epidemiology, classification, and pharmacology of psychedelics and other hallucinogenic substances• Patterns of use across a range of hallucinogens• Clinical presentations associated with hallucinogen use, including intoxication and persistent perceptual changes• Hallucinogen-induced psychiatric conditions and related diagnostic considerations• Evaluation of risks and clinical challenges associated with hallucinogen use• Emerging evidence regarding the potential therapeutic use of psychedelics in substance use disorders• Clinical frameworks for assessing both risks and therapeutic potential in practice
What to Expect
• Live, faculty-led instruction delivered in an interactive online format• Discussion of current trends, clinical challenges, and emerging research related to hallucinogens and psychedelics• Structured content aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas• Case-based examples illustrating assessment, diagnosis, and management considerations• Practical guidance for evaluating hallucinogen-related presentations and emerging therapeutic applications in addiction medicine practice
Joji Suzuki, MD
Dr. Suzuki is Director of the Division of Addiction Psychiatry at Brigham and Women’s Hospital and Program Director of the Addiction Medicine Fellowship. He is an Assistant Professor of Psychiatry at Harvard Medical School.
His work focuses on addiction psychiatry, substance use disorders, and medical psychiatry, with an emphasis on clinical research and medical education. He has received federal research funding and has published extensively in addiction and psychiatric care.
To support a meaningful learning experience and recognize your participation: